Company Filing History:
Years Active: 2014
Title: Anisah Alyahya: Innovator in Therapeutic Vaccination Against Tuberculosis
Introduction
Anisah Alyahya is a prominent inventor based in Leiden, Netherlands. She has made significant contributions to the field of medical innovation, particularly in the development of therapeutic methods for treating active tuberculosis (TB). Her work is crucial in addressing a global health challenge.
Latest Patents
Anisah Alyahya holds a patent for a therapeutic vaccination against active tuberculosis. The invention provides a method for the therapeutic treatment of a patient suffering from active TB. This method involves administering a recombinant adenovirus vector that contains nucleic acid encoding the Ag85A, Ag85B, and TB10.4 antigens of Mycobacterium tuberculosis (Mtb). Notably, this innovative approach can potentially shorten the duration of conventional drug therapy for treating active TB.
Career Highlights
Anisah is associated with Crucell Holland B.V., a company known for its focus on biopharmaceuticals and vaccine development. Her work at Crucell has positioned her as a key player in the fight against infectious diseases, particularly tuberculosis.
Collaborations
Anisah collaborates with Jerald C. Sadoff, who is also involved in the field of vaccine development. Their partnership exemplifies the importance of teamwork in advancing medical research and innovation.
Conclusion
Anisah Alyahya's contributions to therapeutic vaccination against tuberculosis highlight her role as an innovator in the medical field. Her work not only addresses a critical health issue but also paves the way for future advancements in vaccine development.